title: The 5-HT7 receptor as a potential target for treating drug and alcohol abuse.
abstract: Alcohol and drug abuse take a large toll on society and affected individuals. However, very few effective treatments are currently available to treat alcohol and drug addiction. Basic and clinical research has begun to provide some insights into the underlying neurobiological systems involved in the addiction process. Several neurotransmitter pathways have been implicated and distinct reward neurocircuitry have been proposed-including the mesocorticolimbic dopamine (MCL-DA) system and the extended amygdala. The serotonin (5-HT) neurotransmitter system is of particular interest and multiple 5-HT receptors are thought to play significant roles in alcohol and drug self-administration and the development of drug dependence. Among the 5-HT receptors, the 5-HT7 receptor is currently undergoing characterization as a potential target for the treatment of several psychiatric disorders. Although this receptor has received only limited research regarding addictive behaviors, aspects of its neuroanatomical, biochemical, physiological, pharmacological, and behavioral profiles suggest that it could play a key role in the addiction process. For instance, genomic studies in humans have suggested a link between variants in the gene encoding the 5-HT7 receptor and alcoholism. Recent behavioral testing using high-affinity antagonists in mice and preliminary tests with alcohol-preferring rats suggest that this receptor could mediate alcohol consumption and/or reinforcement and play a role in seeking/craving behavior. Interest in the development of new and more selective pharmacological agents for this receptor will aid in examining the 5-HT7 receptor as a novel target for treating addiction.
authors: Department of Psychiatry, Indiana University School of Medicine Indianapolis, IN, USA.
authors: Sheketha R
authors: SR
authors: Hauser
authors: Department of Molecular and Cellular Neuroscience, The Scripps Research Institute La Jolla, CA, USA.
authors: Peter B
authors: PB
authors: Hedlund
authors: Department of Molecular and Cellular Neuroscience, The Scripps Research Institute La Jolla, CA, USA ; Molecular and Cellular Neuroscience Department, Mouse Behavioral Assessment Core, The Scripps Research Institute La Jolla, CA, USA.
authors: Amanda J
authors: AJ
authors: Roberts
authors: Department of Pharmacology, College of Pharmacy and Pharmaceutical Sciences, University of Toledo Toledo, OH, USA.
authors: Youssef
authors: Y
authors: Sari
authors: Department of Psychiatry, Indiana University School of Medicine Indianapolis, IN, USA.
authors: Richard L
authors: RL
authors: Bell
authors: Department of Psychiatry, Indiana University School of Medicine Indianapolis, IN, USA.
authors: Eric A
authors: EA
authors: Engleman
keywords: alcohol abuse; drug abuse; genetics; mesocorticolimbic dopamine system; pharmacogenetics; selective breeding; serotonin-7 (5-HT7)
references: Brain Res. 1994 Jun 6;647(2):307-22
references: 7522922
references: Neuropharmacology. 2006 Sep;51(3):578-86
references: 16828124
references: J Physiol. 1994 Jul 1;478 ( Pt 1):67-73
references: 7965836
references: Arch Gen Psychiatry. 2006 Sep;63(9):957-68
references: 16952998
references: Neurosci Lett. 2001 Aug 31;309(3):141-4
references: 11514061
references: Curr Neuropharmacol. 2006 Oct;4(4):313-39
references: 18654635
references: J Med Chem. 2004 Dec 16;47(26):6616-24
references: 15588097
references: Neurochem Res. 1992 May;17(5):401-7
references: 1356241
references: BMC Biol. 2009 Oct 27;7:70
references: 19874574
references: CNS Neurol Disord Drug Targets. 2006 Oct;5(5):513-20
references: 17073654
references: Psychopharmacology (Berl). 2007 Jun;192(2):291-8
references: 17279375
references: Prog Neuropsychopharmacol Biol Psychiatry. 2013 Jan 10;40:132-7
references: 23367506
references: J Med Chem. 2000 Feb 10;43(3):342-5
references: 10669560
references: Eur J Pharmacol. 2007 Sep 10;570(1-3):72-6
references: 17586491
references: Genes Brain Behav. 2009 Apr;8(3):356-68
references: 19243449
references: Neuroscience. 2011 Sep 8;190:328-38
references: 21684321
references: Br J Pharmacol. 2003 Jun;139(4):705-14
references: 12812993
references: Eur J Pharmacol. 1999 May 28;373(1):13-9
references: 10408247
references: Neuroscience. 2008 Jan 24;151(2):439-51
references: 18082329
references: Neuropharmacology. 2002 Jan;42(1):74-81
references: 11750917
references: J Subst Abuse Treat. 1991;8(4):277-91
references: 1664867
references: Neuropharmacology. 2005 Mar;48(4):492-502
references: 15755477
references: Neuropsychopharmacology. 2014 Apr;39(5):1232-44
references: 24264816
references: J Pharmacol Exp Ther. 1995 Jun;273(3):1139-46
references: 7791084
references: Naunyn Schmiedebergs Arch Pharmacol. 1985 Feb;328(4):467-70
references: 2859533
references: J Med Chem. 2007 Aug 23;50(17):4214-21
references: 17649988
references: Neuropharmacology. 2004 Jun;46(7):935-41
references: 15081790
references: Neuropsychopharmacology. 2011 May;36(6):1275-88
references: 21326194
references: Trends Pharmacol Sci. 2004 Sep;25(9):481-6
references: 15559250
references: Brain Res. 2010 Dec 17;1366:110-9
references: 20920493
references: J Neurosci. 2001 Jul 15;21(14):5351-7
references: 11438611
references: Brain Res Bull. 2000 Sep 15;53(2):187-92
references: 11044595
references: J Pharmacol Exp Ther. 1996 Apr;277(1):40-7
references: 8613947
references: Brain Res Bull. 1989 Dec;23(6):541-7
references: 2575444
references: CNS Drugs. 2004;18(15):1105-18
references: 15581381
references: Pharmacol Rep. 2012;64(6):1305-15
references: 23406741
references: Pharmacol Biochem Behav. 2012 Nov;103(1):119-55
references: 22841890
references: Bioorg Med Chem Lett. 2002 Nov 18;12(22):3341-4
references: 12392747
references: Alcohol. 2010 Mar;44(2):171-83
references: 20116196
references: Behav Brain Res. 2004 Dec 6;155(2):275-82
references: 15364487
references: Pharmacol Biochem Behav. 1987 Feb;26(2):389-92
references: 2437596
references: Neuroscience. 1997 Jul;79(1):171-6
references: 9178873
references: Am J Psychiatry. 2010 Jun;167(6):630-9
references: 20516163
references: Alcohol. 1991 Nov-Dec;8(6):425-31
references: 1723600
references: PLoS One. 2012;7(1):e29369
references: 22253714
references: Prog Neurobiol. 1994 Oct;44(2):221-31
references: 7831478
references: Neuropsychopharmacology. 1999 Sep;21(3):352-67
references: 10457532
references: Br J Pharmacol. 2000 Jun;130(3):539-48
references: 10821781
references: J Psychopharmacol. 2013 Jan;27(1):3-12
references: 23118018
references: Br J Pharmacol. 2004 Jan;141(1):92-104
references: 14656806
references: Psychiatry Res. 1979 Dec;1(3):255-64
references: 298353
references: Neuroimage. 2011 Oct 1;58(3):885-94
references: 21763429
references: Neuropsychopharmacology. 2006 Sep;31(9):1946-56
references: 16319916
references: Trends Pharmacol Sci. 1998 Dec;19(12):491-5
references: 9871410
references: Brain Res. 1997 May 2;755(2):246-54
references: 9175892
references: Brain Res. 1987 Dec 1;435(1-2):71-83
references: 2892580
references: Prog Neurobiol. 1998 Nov;56(4):385-431
references: 9775400
references: J Neurochem. 1994 Aug;63(2):456-64
references: 7518496
references: Neuropharmacology. 1999 Aug;38(8):1083-152
references: 10462127
references: Pharmacol Rep. 2008 Jul-Aug;60(4):464-74
references: 18799814
references: Proc Natl Acad Sci U S A. 1993 Sep 15;90(18):8547-51
references: 8397408
references: J Pharmacol Exp Ther. 1996 Jun;277(3):1560-6
references: 8667223
references: Neurosci Biobehav Rev. 2011 May;35(6):1419-49
references: 21402098
references: Biol Psychiatry. 2005 Nov 15;58(10):831-7
references: 16018977
references: Pharmacol Biochem Behav. 1993 Nov;46(3):631-6
references: 8278440
references: J Pharmacol Exp Ther. 1999 Mar;288(3):1223-8
references: 10027862
references: Ann N Y Acad Sci. 1990;600:9-34; discussion 34-5
references: 2252340
references: Mol Pharmacol. 1993 Aug;44(2):229-36
references: 8394987
references: Brain Res. 1994 Aug 22;654(2):324-30
references: 7987681
references: CNS Spectr. 2014 Apr;19(2):121-33
references: 23903233
references: Addiction. 1993 Jun;88(6):791-804
references: 8329970
references: Pharmacol Biochem Behav. 2002 Jan-Feb;71(1-2):111-7
references: 11812514
references: J Med Chem. 2008 Sep 25;51(18):5813-22
references: 18800769
references: J Biol Rhythms. 2003 Apr;18(2):145-58
references: 12693869
references: J Biol Rhythms. 1993 Spring;8(1):1-16
references: 8490207
references: Neurosci Lett. 2010 Aug 30;481(1):12-6
references: 20600619
references: Eur J Pharmacol. 2005 Jul 25;518(1):30-9
references: 16002064
references: Pain. 2010 Jun;149(3):483-94
references: 20399562
references: Neuroscience. 2007 Jun 29;147(2):428-38
references: 17543469
references: Dev Neurobiol. 2007 Jan;67(1):10-22
references: 17443768
references: Brain Res. 2008 Oct 15;1235:153-71
references: 18634760
references: Am J Addict. 2014 Nov-Dec;23(6):526-39
references: 25278008
references: Neuropharmacology. 2004 Jan;46(1):52-62
references: 14654097
references: Am J Psychiatry. 2011 Mar;168(3):265-75
references: 21247998
references: Receptors Channels. 1995;3(1):61-70
references: 8589994
references: Life Sci. 2004 Dec 17;76(5):521-31
references: 15556165
references: J Comp Neurol. 1978 Jun 1;179(3):641-67
references: 565370
references: Neuroscience. 1981;6(2):115-38
references: 6164006
references: J Med Chem. 1999 Feb 25;42(4):533-5
references: 10052959
references: Behav Brain Res. 2009 Aug 24;202(1):26-31
references: 19447277
references: Biochem Pharmacol. 2008 Jan 1;75(1):266-322
references: 17764663
references: Biochem Pharmacol. 2008 Jan 1;75(1):160-77
references: 17669369
references: Addiction. 2006 Jan;101(1):50-9
references: 16393191
references: Br J Pharmacol. 1996 Feb;117(4):657-66
references: 8646411
references: J Physiol Pharmacol. 2011 Oct;62(5):535-40
references: 22204801
references: Mol Neurobiol. 2011 Jun;43(3):228-53
references: 21424680
references: Neuroscience. 2007 Oct 12;149(1):192-202
references: 17869441
references: Br J Pharmacol. 1995 May;115(1):107-16
references: 7647964
references: DNA Cell Biol. 1993 Jun;12(5):401-9
references: 8517926
references: Pain. 2009 Feb;141(3):239-47
references: 19118950
references: J Biol Chem. 1993 Aug 25;268(24):18200-4
references: 8394362
references: Am J Med Genet B Neuropsychiatr Genet. 2011 Jan;156B(1):44-58
references: 21184583
references: Neuropharmacology. 2011 Sep;61(3):421-32
references: 21466815
references: Neurosci Lett. 2004 Sep 9;367(3):313-6
references: 15337256
references: J Neurosci. 2003 Aug 20;23(20):7451-60
references: 12930783
references: Cogn Affect Behav Neurosci. 2006 Mar;6(1):53-61
references: 16869229
references: Neurochem Res. 2004 Aug;29(8):1487-97
references: 15260125
references: J Neurochem. 1997 Apr;68(4):1372-81
references: 9084407
references: Addict Behav. 2006 Feb;31(2):298-308
references: 15949898
references: J Pharm Pharmacol. 1982 Sep;34(9):591-3
references: 6127387
references: J Biol Chem. 1993 Nov 5;268(31):23422-6
references: 8226867
references: J Med Chem. 1998 Feb 26;41(5):655-7
references: 9513592
references: Brain Res Bull. 1989 Apr;22(4):725-35
references: 2736398
references: Alcohol Clin Exp Res. 2014 Sep;38(9):2354-61
references: 25070732
references: Pharmacol Biochem Behav. 1992 May;42(1):187-92
references: 1388276
references: Pharmacol Ther. 2006 Jan;109(1-2):12-32
references: 15996746
references: PLoS One. 2011;6(6):e20210
references: 21701689
references: J Neurosci. 2000 Aug 1;20(15):5867-73
references: 10908630
references: Brain Res Bull. 2001 Mar 1;54(4):395-8
references: 11306191
references: J Pharmacol Exp Ther. 1994 Mar;268(3):1403-10
references: 7908055
references: Eur J Neurosci. 2012 Apr;35(8):1368-80
references: 22512261
references: CNS Neurol Disord Drug Targets. 2008 Nov;7(5):454-67
references: 19128203
references: Neuron. 1993 Sep;11(3):449-58
references: 8398139
references: Alcohol Clin Exp Res. 1998 Sep;22(6):1272-6
references: 9756042
references: Psychopharmacology (Berl). 2009 Oct;206(3):345-54
references: 19649616
references: Brain Res. 2003 Dec 12;993(1-2):230-4
references: 14642852
references: Alcohol. 1990 May-Jun;7(3):199-205
references: 2184832
references: Psychiatry Res. 1997 Oct 10;72(3):177-85
references: 9406907
references: Neuropharmacology. 2013 Apr;67:337-48
references: 23220399
references: Curr Psychiatry Rep. 2006 Apr;8(2):151-7
references: 16539893
references: Eur J Pharmacol. 2006 Dec 28;553(1-3):185-90
references: 17097082